Phase 1 safety assessment of intrathecal oxytocin

Por Eisenach, James C., Tong, Chuanyao, Curry, Regina
Publicado no Anesthesiology (2015)

Clinical efficacy and safety of apatinib combined with S-1 in advanced esophageal squamous cell carcinoma

Por Zhao, Jian, Lei, Junmei, Yu, Junyan, Zhang, Chengyan, Song, Xuefeng, Zhang, Ninggang, Wang, Yusheng, Zhang, Suxiang
Publicado no Invest New Drugs (2019)

Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom...

Por van de Putte, L B A, Atkins, C, Malaise, M, Sany, J, Russell, A, van Riel, P L C M, Settas, L, Bijlsma, J, Todesco, S, Dougados, M, Nash, P, Emery, P, Walter, N, Kaul, M, Fischkoff, S, Kupper, H
Publicado em 2004

Effectiveness and safety of the interleukin 6-receptor antagonist tocilizumab after 4 and 24 weeks...

Por Burmester, Gerd R, Feist, E, Kellner, H, Braun, J, Iking-Konert, C, Rubbert-Roth, A
Publicado em 2010

Glycyrrhizin in patients who failed previous interferon alpha-based therapies: biochemical and histological effects after 52 weeks

Por Manns, M P, Wedemeyer, H, Singer, A, Khomutjanskaja, N, Dienes, H P, Roskams, T, Goldin, R, Hehnke, U, Inoue, H
Publicado em 2012

Modified FOLFIRINOX as a Second-Line Treatment for Patients with Gemcitabine-Failed Advanced Biliary Tract Cancer: A Prospective Multicenter Phase II Study

Por Yong-Pyo Lee, Sung Yong Oh, Kwang Min Kim, Se-Il Go, Jung Hoon Kim, Seok Jae Huh, Jung Hun Kang, Jun Ho Ji
Publicado em 2022-04-01

Comparison of the OUTBACK(®) Elite Reentry Catheter and the Bi-directional Approach after Failed Antegrade Approach for Femoro-popliteal Occlusive Disease

Por Kawasaki, Daizo, Fukunaga, Masashi, Nakata, Tsuyoshi, Kato, Masaaki, Ohkubo, Nobukazu
Publicado no J Atheroscler Thromb (2017)

Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using Omalizumab

Por Bégin, Philippe, Dominguez, Tina, Wilson, Shruti P, Bacal, Liane, Mehrotra, Anjuli, Kausch, Bethany, Trela, Anthony, Tavassoli, Morvarid, Hoyte, Elisabeth, O’Riordan, Gerri, Blakemore, Alanna, Seki, Scott, Hamilton, Robert G, Nadeau, Kari C
Publicado em 2014

A 12 Week, Open Label, Phase I/IIa Study Using Apatone(®) for the Treatment of Prostate Cancer Patients Who Have Failed Standard Therapy

Por Tareen, Basir, Summers, Jack L., Jamison, James M., Neal, Deborah R., McGuire, Karen, Gerson, Lowell, Diokno, Ananias
Publicado em 2008

Results of a Phase II Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic...

Por Lee, Choong-kun, Jung, Minkyu, Choi, Hye Jin, Kim, Hye Ryun, Kim, Hyo Song, Roh, Mi Ryung, Ahn, Joong Bae, Chung, Hyun Cheol, Heo, Su Jin, Rha, Sun Young, Shin, Sang Joon
Publicado no Cancer Res Treat (2015)

Vascular effects, efficacy and safety of nintedanib in patients with advanced, refractory colorectal cancer: a prospective phase I subanalysis

Por Mross, Klaus, Büchert, Martin, Frost, Annette, Medinger, Michael, Stopfer, Peter, Studeny, Matus, Kaiser, Rolf
Publicado em 2014

Phase 2 ventricular arrhythmias in acute myocardial infarction: a neglected target for therapeutic...

Por Clements-Jewery, Hugh, Hearse, David J, Curtis, Michael J
Publicado em 2005

The efficacy and safety of endovascular recanalization of occluded large cerebral arteries during...

Por Chen, Kangning, Hou, Xianhua, Zhou, Zhenhua, Li, Guangjian, Liu, Qu, Gui, Li, Hu, Jun, Shi, Shugui
Publicado no Stroke Vasc Neurol (2017)

Phase II Study of Olaparib (AZD-2281) After Standard Systemic Therapies for Disseminated Colorectal Cancer

Por Leichman, Lawrence, Groshen, Susan, O’Neil, Bert H., Messersmith, Wells, Berlin, Jordan, Chan, Emily, Leichman, Cynthia G., Cohen, Steven J., Cohen, Deirdre, Lenz, Heinz-Josef, Gold, Philip, Boman, Bruce, Fielding, Anitra, Locker, Gershon, Cason, Ronald C., Hamilton, Stan R., Hochster, Howard S.
Publicado no Oncologist (2016)

Efficacy and Safety of AM-101 in the Treatment of Acute Inner Ear Tinnitus—A Double-Blind, Randomized, Placebo-Controlled Phase II Study

Por van de Heyning, Paul, Muehlmeier, Guido, Cox, Tony, Lisowska, Grazyna, Maier, Heinz, Morawski, Krzysztof, Meyer, Thomas
Publicado em 2014

ACTR-40. PHASE 2 SAFETY AND EFFICACY OF AR-67 (7-T-BUTYLDIMETHYLSILTYL-10-HYDROXYCAMPTOTHECIN...

Por Kumthekar, Priya, Raizer, Jeffrey, Cavaliere, Robert, Devoe, Craig, Jensen, Randy, Stieber, Volker, Runk, Tina, Grewal, Jai, Brownell, Elise, Zukiwski, Alex, Proniuk, Stefan, Arnold, Susanne, Vredenburgh, James
Publicado no Neuro Oncol (2019)

Safety and effectiveness of adalimumab in patients with rheumatoid arthritis over 5 years...

Por Burmester, Gerd R, Matucci-Cerinic, Marco, Mariette, Xavier, Navarro-Blasco, Francisco, Kary, Sonja, Unnebrink, Kristina, Kupper, Hartmut
Publicado em 2014

Phase II Trial of Continuous Regorafenib Dosing in Patients with Gastrointestinal Stromal Tumors After Failure of Imatinib and Sunitinib

Por Kim, Jae‐Joon, Ryu, Min‐Hee, Yoo, Changhoon, Beck, Mo Youl, Ma, Jung Eun, Kang, Yoon‐Koo
Publicado no Oncologist (2019)

Phase I/II study of metastatic melanoma patients treated with nivolumab who had progressed after ipilimumab

Por Weber, Jeffrey, Gibney, Geoffrey, Kudchadkar, Ragini, Yu, Bin, Cheng, PingYan, Martinez, Alberto J., Kroeger, Jodie, Richards, Allison, McCormick, Lori, Moberg, Valerie, Cronin, Heather, Zhao, Xiuhua, Schell, Michael, Chen, Yian Ann
Publicado no Cancer Immunol Res (2016)

Endoscopic treatment of esophageal fistulas after esophagectomy with injection of an alpha-cyanoacrylate monomer: a phase II study

Por Ojima, Toshiyasu, Nakamura, Masaki, Nakamori, Mikihito, Katsuda, Masahiro, Hayata, Keiji, Tsuji, Toshiaki, Maruoka, Shimpei, Yamaue, Hiroki
Publicado no Endosc Int Open (2018)